tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide

C132H163BrCl2N26O13S2 — CID 159932901

IUPACtert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide
SMILESCc1cc(C2CC2)nc2cc([C@@H]3CCCCN3C(=O)C(NC(=O)OC(C)(C)C)c3cccc(Cl)c3)nn12.Cc1cc(C2CC2)nc2cc([C@@H]3CCCCN3C(=O)C(NC(=O)OC(C)(C)C)c3ccccc3Br)nn12.Cc1cc(C2CC2)nc2cc([C@@H]3CCCCN3C(=O)C(c3ccccc3)N(C)C)nn12.Cc1cc(C2CC2)nc2cc([C@@H]3CCCCN3C(=O)[C@](C)(NS(C)(=O)=O)c3ccccc3)nn12.Cc1nc2cc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)nn2c(N2CCCCC2)c1C
InChIInChI=1S/C28H34BrN5O3.C28H34ClN5O3.C26H33ClN6O3S.C25H31N5O3S.C25H31N5O/c1-17-15-21(18-12-13-18)30-24-16-22(32-34(17)24)23-11-7-8-14-33(23)26(35)25(19-9-5-6-10-20(19)29)31-27(36)37-28(2,3)4;1-17-14-21(18-11-12-18)30-24-16-22(32-34(17)24)23-10-5-6-13-33(23)26(35)25(19-8-7-9-20(29)15-19)31-27(36)37-28(2,3)4;1-17-18(2)28-24-16-22(29-33(24)25(17)31-12-6-4-7-13-31)23-9-5-8-14-32(23)26(34)20-15-19(27)10-11-21(20)30-37(3,35)36;1-17-15-20(18-12-13-18)26-23-16-21(27-30(17)23)22-11-7-8-14-29(22)24(31)25(2,28-34(3,32)33)19-9-5-4-6-10-19;1-17-15-20(18-12-13-18)26-23-16-21(27-30(17)23)22-11-7-8-14-29(22)25(31)24(28(2)3)19-9-5-4-6-10-19/h5-6,9-10,15-16,18,23,25H,7-8,11-14H2,1-4H3,(H,31,36);7-9,14-16,18,23,25H,5-6,10-13H2,1-4H3,(H,31,36);10-11,15-16,23,30H,4-9,12-14H2,1-3H3;4-6,9-10,15-16,18,22,28H,7-8,11-14H2,1-3H3;4-6,9-10,15-16,18,22,24H,7-8,11-14H2,1-3H3/t2*23-,25?;23-;22-,25+;22-,24?/m00000/s1
InChIKeyNZWIHITYAHHHDT-BHTMUCOPSA-N
MW2536.87 g/mol
LogP24.32
Rot. Bonds26

About tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide

tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide (PubChem CID 159932901) has the molecular formula C132H163BrCl2N26O13S2 and a molecular weight of 2536.87 g/mol. Its IUPAC name is tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide.

Molecular Properties

Compound Nametert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide
PubChem CID159932901
Molecular FormulaC132H163BrCl2N26O13S2
Molecular Weight2536.87 g/mol
Exact Mass2533.09
IUPAC Nametert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide
SMILESCc1cc(C2CC2)nc2cc([C@@H]3CCCCN3C(=O)C(NC(=O)OC(C)(C)C)c3cccc(Cl)c3)nn12.Cc1cc(C2CC2)nc2cc([C@@H]3CCCCN3C(=O)C(NC(=O)OC(C)(C)C)c3ccccc3Br)nn12.Cc1cc(C2CC2)nc2cc([C@@H]3CCCCN3C(=O)C(c3ccccc3)N(C)C)nn12.Cc1cc(C2CC2)nc2cc([C@@H]3CCCCN3C(=O)[C@](C)(NS(C)(=O)=O)c3ccccc3)nn12.Cc1nc2cc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)nn2c(N2CCCCC2)c1C
InChIInChI=1S/C28H34BrN5O3.C28H34ClN5O3.C26H33ClN6O3S.C25H31N5O3S.C25H31N5O/c1-17-15-21(18-12-13-18)30-24-16-22(32-34(17)24)23-11-7-8-14-33(23)26(35)25(19-9-5-6-10-20(19)29)31-27(36)37-28(2,3)4;1-17-14-21(18-11-12-18)30-24-16-22(32-34(17)24)23-10-5-6-13-33(23)26(35)25(19-8-7-9-20(29)15-19)31-27(36)37-28(2,3)4;1-17-18(2)28-24-16-22(29-33(24)25(17)31-12-6-4-7-13-31)23-9-5-8-14-32(23)26(34)20-15-19(27)10-11-21(20)30-37(3,35)36;1-17-15-20(18-12-13-18)26-23-16-21(27-30(17)23)22-11-7-8-14-29(22)24(31)25(2,28-34(3,32)33)19-9-5-4-6-10-19;1-17-15-20(18-12-13-18)26-23-16-21(27-30(17)23)22-11-7-8-14-29(22)25(31)24(28(2)3)19-9-5-4-6-10-19/h5-6,9-10,15-16,18,23,25H,7-8,11-14H2,1-4H3,(H,31,36);7-9,14-16,18,23,25H,5-6,10-13H2,1-4H3,(H,31,36);10-11,15-16,23,30H,4-9,12-14H2,1-3H3;4-6,9-10,15-16,18,22,28H,7-8,11-14H2,1-3H3;4-6,9-10,15-16,18,22,24H,7-8,11-14H2,1-3H3/t2*23-,25?;23-;22-,25+;22-,24?/m00000/s1
InChIKeyNZWIHITYAHHHDT-BHTMUCOPSA-N
XLogP24.32
TPSA427.98 Ų
H-Bond Donors4
H-Bond Acceptors30
Rotatable Bonds26
Heavy Atoms176
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002536.87
LogP ≤ 524.32
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1030

Analyze tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide?
The IUPAC name of tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide (CID 159932901) is tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide.
What is the SMILES notation for tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide?
The canonical SMILES for tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide is Cc1cc(C2CC2)nc2cc([C@@H]3CCCCN3C(=O)C(NC(=O)OC(C)(C)C)c3cccc(Cl)c3)nn12.Cc1cc(C2CC2)nc2cc([C@@H]3CCCCN3C(=O)C(NC(=O)OC(C)(C)C)c3ccccc3Br)nn12.Cc1cc(C2CC2)nc2cc([C@@H]3CCCCN3C(=O)C(c3ccccc3)N(C)C)nn12.Cc1cc(C2CC2)nc2cc([C@@H]3CCCCN3C(=O)[C@](C)(NS(C)(=O)=O)c3ccccc3)nn12.Cc1nc2cc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)nn2c(N2CCCCC2)c1C.
What is the InChIKey of tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide?
The InChIKey is NZWIHITYAHHHDT-BHTMUCOPSA-N. The full InChI is InChI=1S/C28H34BrN5O3.C28H34ClN5O3.C26H33ClN6O3S.C25H31N5O3S.C25H31N5O/c1-17-15-21(18-12-13-18)30-24-16-22(32-34(17)24)23-11-7-8-14-33(23)26(35)25(19-9-5-6-10-20(19)29)31-27(36)37-28(2,3)4;1-17-14-21(18-11-12-18)30-24-16-22(32-34(17)24)23-10-5-6-13-33(23)26(35)25(19-8-7-9-20(29)15-19)31-27(36)37-28(2,3)4;1-17-18(2)28-24-16-22(29-33(24)25(17)31-12-6-4-7-13-31)23-9-5-8-14-32(23)26(34)20-15-19(27)10-11-21(20)30-37(3,35)36;1-17-15-20(18-12-13-18)26-23-16-21(27-30(17)23)22-11-7-8-14-29(22)24(31)25(2,28-34(3,32)33)19-9-5-4-6-10-19;1-17-15-20(18-12-13-18)26-23-16-21(27-30(17)23)22-11-7-8-14-29(22)25(31)24(28(2)3)19-9-5-4-6-10-19/h5-6,9-10,15-16,18,23,25H,7-8,11-14H2,1-4H3,(H,31,36);7-9,14-16,18,23,25H,5-6,10-13H2,1-4H3,(H,31,36);10-11,15-16,23,30H,4-9,12-14H2,1-3H3;4-6,9-10,15-16,18,22,28H,7-8,11-14H2,1-3H3;4-6,9-10,15-16,18,22,24H,7-8,11-14H2,1-3H3/t2*23-,25?;23-;22-,25+;22-,24?/m00000/s1.
What are the key properties of tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide?
tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide has a molecular weight of 2536.87 g/mol, XLogP of 24.32, 26 rotatable bonds, 4 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl N-[1-(2-bromophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;tert-butyl N-[1-(3-chlorophenyl)-2-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-oxoethyl]carbamate;N-[4-chloro-2-[(2S)-2-(5,6-dimethyl-7-piperidin-1-ylpyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carbonyl]phenyl]methanesulfonamide;1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-2-(dimethylamino)-2-phenylethanone;N-[(2R)-1-[(2S)-2-(5-cyclopropyl-7-methylpyrazolo[1,5-a]pyrimidin-2-yl)piperidin-1-yl]-1-oxo-2-phenylpropan-2-yl]methanesulfonamide is sourced from PubChem (CID 159932901), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).